| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |